Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard   

Previous Fragment    Next Fragment
Wednesday, 10 October 1984
Page: 1513

To the Honourable the President and members of the Senate in the Parliament assembled. The humble petition of Merck Sharp & Dohme (Australia) Pty Limited located in the State of New South Wales, respectfully showeth that the pharmaceutical industry in Australia views with concern the failure in Government policy to recognise sufficiently the importance of brand-name products, developed by research-based companies;

Since the progress in development of new, safe and effective pharmaceuticals is vitally dependent on the economic viability of a research-based pharmaceutical industry;

Since the economic viability is a pre-condition for the continued employment of our well educated and skilled workforce in all aspects of the industry activity;

Since full information and reliable technical back-up can only be provided in easily accessible form from product information available from the research- based companies which are product originators.

Your petitioner therefore humbly prays that the Commonwealth Government initiate policies which ensure that continued access of Australians to safe and effective pharmaceuticals is secured through encouraging growth of a research- based pharmaceutical manufacturing industry in Australia.

And your petitioner as in duty bound will ever pray.